MAVA in Action: Launch Strategy Shifted in Just 5 Days
- Sep 30, 2025
- 1 min read
Launch plans rarely survive first contact with payers.
One immunology manufacturer learned this firsthand. Their internal strategy had a clear value story, aligned teams, and a rebate framework they believed would secure access.
Then they tested it with MAVA®.
Launch was approaching fast.
The team needed payer validation on their contracting model and evidence package.
Waiting months for a traditional advisory board wasn’t possible.
They needed answers in days, not quarters.
With MAVA, In less than a week, the manufacturer:
Gathered
direct feedback
from national and regional payers on rebate thresholds.
Uncovered
evidence gaps
that could raise red flags in a P&T committee.
Ran
scenario modeling
with Elasticity™ and Contracting ROI to see how different strategies would play out in the market.
All of it happened inside MAVA: a secure, digital environment designed to deliver insights at the speed of market access.
The results were decisive:
The value story was reframed to emphasize payer-relevant endpoints.
Contracting offers were restructured to balance rebates with margin protection.
A potential launch misstep that would have eroded long-term value was avoided.
— Senior Director, Medical Payer Strategy
Market access moves faster than static plans. With MAVA, manufacturers don’t wait months for advisory boards, they
pressure-test strategies with real payers in just five days
.
Faster insight. Better outcomes. That’s MAVA in action.
